Mereo BioPharma Group PLC ADR (MREO) stock news · $48.7M cap
Mereo BioPharma Group PLC ADR (MREO) is a biotechnology company listed on US.
This MREO news page leads with what Mereo BioPharma Group PLC ADR filed — not a scraped headline mill.
No cached 8-K sentence for MREO yet. We will not pad this page with generic market recap.
Latest reported MREO revenue for 2026-06-30 was $0. Net income was -$7.0M. Revenue was down 100.0% from 2026-03-31 to 2026-06-30. MREO currently screens at market cap $48.7M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the MREO stock page; for the tape open the quote page.
Not investment advice.